The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3–4 CKD

Kamyar Kalantar-Zadeh, Christopher S. Hollenbeak, Roy Arguello, Sophie Snyder, Akhtar Ashfaq

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3–4 CKD'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences